Gene Set Enrichment Analysis (GSEA) revealed high activation of breast cancer pathway (Figure S3A, Supporting Information) and MAPK (Figure S3B, Supporting Information) signaling in the Fgfr2‐S252W mammary glands compared with those of MMTV‐Cre. This evidence concerns the gene FGFR2 and breast carcinoma.